
Wed 15 October 2025
Warszawa (PL)
5/6°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
12 |
11 |
11 |
11 |
12 |
Wed 15 October 2025
Praha (CZ)
10/9°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
16 |
13 |
14 |
14 |
14 |
Wed 15 October 2025
Bratislava (SK)
11/6°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
14 |
13 |
14 |
15 |
15 |
Wed 15 October 2025
Budapest (HU)
10/6°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
17 |
15 |
15 |
16 |
17 |



March 3rd, 2021
Mabion, a Polish biotech company, will manufacture a Covid-19 vaccine under a licence with US pharmaceutical firm Novavax. Mabion has signed a deal with Novavax for the transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine which is yet to be approved by the EU's medical agency, Mabion said in a statement on Wednesday.
PAP
Pageviews this month:
102,050